Related Articles
Clinical implications of urokinase and tissue type plasminogen activators and their inhibitor (PAI-1) in breast cancer tissue
Immunolocalization of the components of the plasminogen activating system in breast carcinoma tissue
<em>In situ</em> hybridization for the assessment of urokinase plasminogen activator and plasminogen activator inhibitor type‑1 in formalin‑fixed paraffin‑embedded breast cancer specimens
Combined evaluation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression in gastric carcinoma
Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment